Skip to content
Bioptimus

Bioptimus

Biotech·France·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns Bioptimus?

Bioptimus is currently owned by Andera Partners through BioDiscovery 7 (2025 vintage), since 2025. Across its history, Bioptimus has been through 7 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Andera Partners
Most recent investor
Andera Partners
BioDiscovery 7 · 2025 · VC
7 ownership periods · full history below

Key facts

HQFrance
SectorBiotech
Key takeaways
  • ·Co-held by Sofinnova Partners, FRST Capital, Bpifrance Investissement, Felix Capital, Hitachi Ventures, Cathay Capital and Andera Partners since 2024.
  • ·7 distinct PE sponsors across ownership cycles.

Ownership history

7 ownership periods · co-invest detected

Co-invest · 7 holders · 2024 · present
Sofinnova Partners
2024 · present(2yr) · Sofinnova Digital Medicine I · 2022 · VC
FRST Capital
2024 · present(2yr) · Frst 3 · 2023 · VC
Andera Partners
2025 · present(1yr) · BioDiscovery 7 · 2025 · VC
Cathay Capital
2025 · present(1yr) · Cathay Innovation Fund III · 2024 · VC
Hitachi Ventures
2025 · present(1yr) · Hitachi Ventures Fund III · 2023 · VC
Felix Capital
2025 · present(1yr) · Felix Capital Fund IV · 2021 · VC
Bpifrance Investissement
2025 · present(1yr) · Large Venture · 2013 · Growth
Track Bioptimus

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Bioptimus?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Bioptimus.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue